Control of Cancer Cachexia by Suppression of Post Pradial Glycogenesis (1993)

Title:

Control of Cancer Cachexia by Suppression of Post Pradial Glycogenesis

Key words:

3-mercatopicolinic acid, gluconeogenesis

Research Institution:

King's College London

Location:

United Kingdom

Researcher:

Peter W Emery

Project Description:

Dr. Emery looked at the effect of 3-mercatopicolinic acid (3-MDA) as an inhibitor of gluconeogenesis. He attempted to normalize the rate of glycogenesis in the liver in hopes of avoiding cancer cachexia and allowing for more aggressive treatments for cancer patients.